Capricor Therapeutics Inc. (NASDAQ: CAPR)
$4.79
+0.1300 ( +2.79% ) 212.0K
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
Market Data
Open
$4.79
Previous close
$4.66
Volume
212.0K
Market cap
$153.18M
Day range
$4.68 - $4.89
52 week range
$2.68 - $8.22
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 65 | Mar 11, 2024 |
8-k | 8K-related | 16 | Feb 29, 2024 |
8-k | 8K-related | 12 | Jan 11, 2024 |
4 | Insider transactions | 1 | Jan 04, 2024 |
4 | Insider transactions | 1 | Jan 04, 2024 |
4 | Insider transactions | 1 | Jan 04, 2024 |
4 | Insider transactions | 1 | Jan 04, 2024 |
4 | Insider transactions | 1 | Jan 04, 2024 |
4 | Insider transactions | 1 | Jan 04, 2024 |
4 | Insider transactions | 1 | Jan 04, 2024 |